Garnet Anderson Katie Arnold SWOG Statistical Center Fred Hutchinson Cancer Research Center October 24, 2014.

Slides:



Advertisements
Similar presentations
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
Advertisements

When Should a Clinical Trial Design with Pre-Stratification be Used? Group 1.
Agency for Healthcare Research and Quality (AHRQ)
Controlling for Time Dependent Confounding Using Marginal Structural Models in the Case of a Continuous Treatment O Wang 1, T McMullan 2 1 Amgen, Thousand.
Assessing the Effects of Time-varying Predictors or Treatments: A Conceptual Discussion Daniel Almirall VA Medical Center, HSRD Duke Medical Center, Dept.
M2 Medical Epidemiology
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Analysis & Expressing Resultd in Clinical Trials Dr. Khalili.
S MBO Professional Slide Set, Version 01
Integrating nutritional support into the care pathway for colorectal cancer patients Dr Sorrel Burden Lead Dietitian & Macmillan/NIHR Fellow.
Some comments on the 3 papers Robert T. O’Neill Ph.D.
Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.
Modified Megestrol The Clinical Trials by : Carolina R. Akib
Chance, bias and confounding
Biostatistics ~ Types of Studies. Research classifications Observational vs. Experimental Observational – researcher collects info on attributes or measurements.
Biostatistics and Research Design, #6350 Sampling
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Chapter 51 Experiments, Good and Bad. Chapter 52 Experimentation u An experiment is the process of subjecting experimental units to treatments and observing.
Power and Non-Inferiority Richard L. Amdur, Ph.D. Chief, Biostatistics & Data Management Core, DC VAMC Assistant Professor, Depts. of Psychiatry & Surgery.
1 Lecture 20: Non-experimental studies of interventions Describe the levels of evaluation (structure, process, outcome) and give examples of measures of.
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
Mohsen Askarishahi Reference: 1)Aviva Petrie. Medical Statistics at a Glance. Blackwell (2005) 2) Sheldon M. Ross. Introductory Statistics. Elsevier Inc.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Socioeconomic Status and Health Care Outcomes Jianhui Hu, Ph.D., Research Associate Center for Health Policy & Health Services Research Henry Ford Health.
The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,
S1316 – The Malignant Bowel Obstruction Study Forms and Procedures Katie Arnold, MS SWOG Statistical Center Seattle, WA 10/24/2014S1316 Training1.
Disclosures u Dr. Spertus discloses that he is a founder of Health Outcomes Sciences ( that disseminates and supports the PRISM tool.
EDRN Approaches to Biomarker Validation DMCC Statisticians Fred Hutchinson Cancer Research Center Margaret Pepe Ziding Feng, Mark Thornquist, Yingye Zheng,
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases Division, University of Louisville Chief, Infectious Diseases Section, Veterans.
Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
Introduction to confounding and DAGs
Alec Walker September 2014 Core Characteristics of Randomized Clinical Trials.
1 THE ROLE OF COVARIATES IN CLINICAL TRIALS ANALYSES Ralph B. D’Agostino, Sr., PhD Boston University FDA ODAC March 13, 2006.
Clinical Trials: Introduction from an Epidemiologic Study Design Perspective Health Sciences Center Health Sciences Center School of Public Health & Stanley.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
Risk Stratified Analysis Improves Prediction of Treatment Benefit Over Subgroup Analysis: Findings from Intergroup N9741 HK Sanoff, ME Campbell, HC Pitot,
Survival Analysis 1 Always be contented, be grateful, be understanding and be compassionate.
How to Analyze Therapy in the Medical Literature (part 1) Akbar Soltani. MD.MSc Tehran University of Medical Sciences (TUMS) Shariati Hospital
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
Study designs. Kate O’Donnell General Practice & Primary Care.
THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Personal Health Budgets Evaluation Evaluation of the Personal Health Budgets Pilots Wider Cohort Pilot Sites.
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Characteristics of Studies that might Meet the What Works Clearinghouse Standards: Tips on What to Look For 1.
Ten things about Experimental Design AP Statistics, Second Semester Review.
Article Title Resident Name, MD SVCH6/13/2016 Journal Club.
Collecting Sample Data Chapter 1 Section 4 Part 2.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Analytical Observational Studies
Methods to Handle Noncompliance
- Higher SBP visit-to-visit variability (SBV) has been associated
WHI Cancer Survivor Cohort (CSC)
Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.
Donald E. Cutlip, MD Beth Israel Deaconess Medical Center
Randomized Trials: A Brief Overview
S1316 – The Malignant Bowel Obstruction Study A Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction SWOG Study Chairs: Robert S.
Process Indicators for Patient Navigation
Chapter 7 The Hierarchy of Evidence
S1316 – The Malignant Bowel Obstruction Study A Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction SWOG Study Chairs: Robert S.
S1316 analysis details Garnet Anderson Katie Arnold
Managing Depression is a Team Effort:
Observational Studies vs. Randomized Controlled Trials (RCT)
Physical Activity and Endometrial Cancer Survival
Prospective Cohort Study of Body Image Disturbance in Surgically-Managed Head and Neck Cancer Patients Evan Graboyes MD Department of Otolaryngology-Head.
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials E Mitry, A Fields,
Approaches and Challenges in Accounting for Baseline and Post-Baseline Characteristics when Comparing Two Treatments in an Observational/Non-Randomized.
Translating Data From Trial to Practice
Presentation transcript:

Garnet Anderson Katie Arnold SWOG Statistical Center Fred Hutchinson Cancer Research Center October 24, 2014

Consent to Randomization Surgery Best Medical Care Surgery Best Medical Care Yes No

 Outcome: Number of “good” days (D) Counted from day of randomization or enrollment through day 91  Design factor: Consent to be randomized (C)  Treatment: Surgery vs Best Medical Care (S)  Adjustment factors (X) Cancer site: colorectal vs ovarian vs other Patient and disease characteristics Provider characteristics

Good Days (D) = function of :  0 +  1 *X Baseline, adjustment factors +  2 *C Difference between randomized and non-randomized cohorts +  1 * S Effect of surgery +  2 * S*C Difference in effect of surgery between randomized and non-randomized cohorts

 Intent-to-treat (ITT) and pseudo ITT based on treatment choice at consent  After controlling for all known confounders, determine if surgery effect is similar across cohorts (Is  2 = 0?) If so, estimated effect of surgery is  1 based on all data If not,   1 is the estimated surgery effect based on RCT alone   2 is an estimate of the bias in the non-randomized study

Consent to Randomization Surgery Best Medical Care Surgery Best Medical Care Yes No     

 Need patients randomized at each site  Monitoring treatment choices in the non- randomized component  Collection of confounder variables for the multivariate analysis  Need all patients managed and monitored identically after initial treatment choice